MSB 2.73% $1.07 mesoblast limited

CHF - The real phase 3 headlines

  1. 4,011 Posts.
    lightbulb Created with Sketch. 5141
    More protection:
    99.8% confidence amongst all treated patients that there was a 60% reduction of non fatal stroke / Heart attacks.

    Disease modifying:
    99.6% confidence that treated class 2 patients never progressed to being class 3 over a 20 month period.

    Better Outcomes:
    96.3% confidence of a 60% mortality reduction in 206 class 2 patient group treated vs control

    I cannot wait for the partership announcement. Its going to shock a load of people. There will be no burning of shorts.... vaporisation only.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.030(2.73%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.11 $1.21 $1.05 $28.73M 25.63M

Buyers (Bids)

No. Vol. Price($)
3 14264 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.08 24626 3
View Market Depth
Last trade - 16.10pm 02/05/2024 (20 minute delay) ?
Last
$1.08
  Change
-0.030 ( 2.52 %)
Open High Low Volume
$1.10 $1.21 $1.05 5190842
Last updated 15.59pm 02/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.